The global amyloidosis therapeutics market size is calculated at USD 3.18 billion in 2025 and is forecasted to reach around USD 6.45 billion by 2034, accelerating at a CAGR of 8.18% from 2025 to 2034. The North America market size surpassed USD 1.38 billion in 2024 and is expanding at a CAGR of 8.28% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
Amyloidosis Therapeutics Market Key Takeaways
- North America dominated the global market with the highest share of 47% in 2024.
- Asia Pacific is estimated to expand at the fastest CAGR in the market between 2025 and 2034.
- By treatment, the chemotherapy segment held the largest market share in 2024.
- By treatment, the transplantation segment is anticipated to grow at a remarkable CAGR between 2025 and 2034.
- By end user, the hospitals and clinics segment dominated the market with the largest share in 2024
- By end user, the home care settings segment is anticipated to show fastest growth during the predicted timeframe
News Url